VYXEOS® Efficacy - Phase 3 Trial Data vs 7+3 | VYXEOS® (daunorubicin and cytarabine)
Cancers | Free Full-Text | Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
survival - Time to event analysis - median (IQR) is <75% experience event - Cross Validated
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
NEJM on Twitter: "Nivolumab increases median overall survival by 5.4 months in adv renal cell cancer. #ECC2015 http://t.co/9DSZcnbnAs http://t.co/22qcFuEfzN" / Twitter
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
IMFINZI® (durvalumab) Efficacy & Clinical Trials for ES-SCLC
Cureus | Impact of CyberKnife Radiosurgery on Median Overall Survival of Various Parameters in Patients with 1-12 Brain Metastases | Article
Definición de la magnitud del resultado clínico basado en la supervivencia individual o en la mediana de supervivencia global
View Image
MARGENZA® Clinical Results
View Image
Median Overall Survival (mOS) | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters | PLOS ONE
Median overall survival (mOS) and median progression-free survival... | Download Scientific Diagram
Kaplan-Meier survival curve comparing median overall survival between... | Download Scientific Diagram
Median Overall Survival (mOS) | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma | Anticancer Research
Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram
Kaplan–Meier survival curves. (A) Median overall survival was... | Download Scientific Diagram
Cureus | Impact of CyberKnife Radiosurgery on Median Overall Survival of Various Parameters in Patients with 1-12 Brain Metastases | Media
Survival curves. (A) Overall survival (median 18.2 months). (B) PS of... | Download Scientific Diagram
Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with (“pseudo-randomized”) treatment allocation by the health insurance provider | SpringerLink
